Journal Article

DZNE-2025-00041

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase-dependent mechanism.

Gilsbach, B. K. (First author)DZNE* ; Ho, F. Y. ; Riebenbauer, B.DZNE* ; Zhang, X. ; Guaitoli, G.DZNE* ; Kortholt, A. ; Gloeckner, C. J. (Last author)DZNE*

2024
eLife Sciences Publications Cambridge

This record in other databases:    

Please use a persistent id in citations: doi:10.7554/eLife.91083

Abstract: The Parkinson's disease (PD)-linked protein Leucine-Rich Repeat Kinase 2 (LRRK2) consists of seven domains, including a kinase and a Roc G domain. Despite the availability of several high-resolution structures, the dynamic regulation of its unique intramolecular domain stack is nevertheless still not well understood. By in-depth biochemical analysis, assessing the Michaelis-Menten kinetics of the Roc G domain, we have confirmed that LRRK2 has, similar to other Roco protein family members, a KM value of LRRK2 that lies within the range of the physiological GTP concentrations within the cell. Furthermore, the R1441G PD variant located within a mutational hotspot in the Roc domain showed an increased catalytic efficiency. In contrast, the most common PD variant G2019S, located in the kinase domain, showed an increased KM and reduced catalytic efficiency, suggesting a negative feedback mechanism from the kinase domain to the G domain. Autophosphorylation of the G1+2 residue (T1343) in the Roc P-loop motif is critical for this phosphoregulation of both the KM and the kcat values of the Roc-catalyzed GTP hydrolysis, most likely by changing the monomer-dimer equilibrium. The LRRK2 T1343A variant has a similar increased kinase activity in cells compared to G2019S and the double mutant T1343A/G2019S has no further increased activity, suggesting that T1343 is crucial for the negative feedback in the LRRK2 signaling cascade. Together, our data reveal a novel intramolecular feedback regulation of the LRRK2 Roc G domain by a LRRK2 kinase-dependent mechanism. Interestingly, PD mutants differently change the kinetics of the GTPase cycle, which might in part explain the difference in penetrance of these mutations in PD patients.

Keyword(s): Leucine-Rich Repeat Serine-Threonine Protein Kinase-2: metabolism (MeSH) ; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2: genetics (MeSH) ; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2: chemistry (MeSH) ; Humans (MeSH) ; Phosphorylation (MeSH) ; Guanosine Triphosphate: metabolism (MeSH) ; Kinetics (MeSH) ; Protein Domains (MeSH) ; Parkinson Disease: genetics (MeSH) ; Parkinson Disease: metabolism (MeSH) ; Feedback, Physiological (MeSH) ; GTPase ; LRRK2 ; Michaelis–Menten kinetics ; PD ; biochemistry ; chemical biology ; negative feedback loop ; none ; parkinson's disease ; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 ; LRRK2 protein, human ; Guanosine Triphosphate

---

Contributing Institute(s):

1. Functional Neuroproteomics and Translational Biomarkers in Neurodegenerative Diseases (AG Gloeckner)
2. Parkinson Genetics (AG Gasser)

Research Program(s):

1. 352 - Disease Mechanisms (POF4-352) (POF4-352)
2. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

---

Database coverage:
; ; ; ; Article Processing Charges ; BIOSIS Previews ; Biological Abstracts ; Clarivate Analytics Master Journal List ; DOAJ Seal ; Ebsco Academic Search ; Essential Science Indicators ; Fees ; IF >= 5 ; JCR ; PubMed Central ; SCOPUS ; Science Citation Index Expanded ; Web of Science Core Collection ; Zoological Record

---